Beclometasone dry-powder inhalation - Chiesi
Alternative Names: Beclometasone DPI; Beclometasone Pulvinal - Chiesi; Beclomethasone dry-powder inhalation - Chiesi; Beclomethasone Pulvinal - Chiesi; ClenilPulvinal; Easivent BDP; Pulvinal BeclometasoneLatest Information Update: 19 Dec 2021
At a glance
- Originator Chiesi
- Developer Chiesi; Trinity-Chiesi Pharmaceuticals
- Class Anti-inflammatories; Antiallergics; Antiasthmatics; Chlorinated steroids; Corticosteroids; Pregnadienetriols; Small molecules; Vascular disorder therapies
- Mechanism of Action Immunosuppressants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Asthma
Most Recent Events
- 13 Jul 2020 Chiesi Farmaceutici and Bayer entered into a co-promotion agreement for Clenil® for Chronic respiratory diseases in China
- 18 Sep 2001 Launched for Asthma in United Kingdom (Inhalation)
- 09 Jul 2001 Launched for Asthma in Italy (Inhalation)